{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:22:02Z","timestamp":1787232122066,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF-CRF-2019-030"],"award-info":[{"award-number":["XJTU1AF-CRF-2019-030"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970329"],"award-info":[{"award-number":["81970329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35797","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T02:54:37Z","timestamp":1722653677000},"page":"e35797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of precise prevention strategies for the occurrence and progression of coronary atherosclerotic heart disease using machine learning"],"prefix":"10.1016","volume":"10","author":[{"given":"Qingfeng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.heliyon.2024.e35797_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"American heart association council on Epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.heliyon.2024.e35797_bib2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35797_bib3","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35797_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35797_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12872-018-0761-0","article-title":"Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35797_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.26599\/1671-5411.2023.06.001","volume":"20","year":"2023","journal-title":"J Geriatr Cardiol"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35797_bib7","first-page":"559","article-title":"Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015","volume":"32","author":"Song","year":"2019","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.heliyon.2024.e35797_bib8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: from physiology to public health","volume":"63","author":"Levey","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35797_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12933-019-0930-1","article-title":"Genetic predisposition to type 2 diabetes is associated with. severity of coronary artery disease in patients with acute coronary syndromes","volume":"18","author":"Zheng","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2024.e35797_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2019.05.012","article-title":"A guide for Gensini Score calculation","volume":"287","author":"Rampidis","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.heliyon.2024.e35797_bib11","first-page":"2311","article-title":"Screening of feature genes in distinguishing different types of breast cancer using support vector machine","volume":"8","author":"Wang","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.heliyon.2024.e35797_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fcvm.2020.00100","article-title":"Glycemia and atherosclerotic cardiovascular disease: exploring the gap between risk marker and risk factor","volume":"7","author":"Nahmias","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35797_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9548","key":"10.1016\/j.heliyon.2024.e35797_bib14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35797_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence. after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35797_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00125-019-4928-8","article-title":"Does diabetes prevention translate into reduced long-term vascular complications of diabetes?","volume":"62","author":"Nathan","year":"2019","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e35797_bib17","first-page":"S111","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e35797_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"SUSTAIN-6 investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e35797_bib19","first-page":"S179","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35797_bib20","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the. Management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e35797_bib21","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Council on Epidemiology and prevention; and stroke council. Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35797_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e35797_bib23","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/01.CIR.0000018121.67607.CE","article-title":"Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men","volume":"105","author":"McGill","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35797_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"STEP 1 study group. Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e35797_bib25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.120.052386","article-title":"Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study","volume":"143","author":"Doumouras","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e35797_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCULATIONAHA.120.048585","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with previous myocardial infarction and severe obesity: a nationwide cohort study","volume":"143","author":"N\u00e4slund","year":"2021","journal-title":"Circulation"},{"issue":"9841","key":"10.1016\/j.heliyon.2024.e35797_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"25 Suppl 2","key":"10.1016\/j.heliyon.2024.e35797_bib28","first-page":"S76","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e35797_bib29","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e35797_bib30","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e35797_bib31","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMra1806939","article-title":"Lipid management for the prevention of atherosclerotic cardiovascular disease","volume":"381","author":"Michos","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"39","key":"10.1016\/j.heliyon.2024.e35797_bib32","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35797_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"10057","key":"10.1016\/j.heliyon.2024.e35797_bib34","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people. with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35797_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41591-021-01634-w","article-title":"Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)","volume":"28","author":"Koren","year":"2022","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e35797_bib36","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2022.5050","article-title":"Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels","volume":"327","author":"Nissen","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35797_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108389","article-title":"Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases","volume":"37","author":"Handelsman","year":"2023","journal-title":"J. Diabet. Complicat."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35797_bib38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/diagnostics13050929","article-title":"The triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease","volume":"13","author":"Kosmas","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35797_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(23)00227-9","article-title":"The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024118282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024118282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:42:22Z","timestamp":1784065342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024118282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024118282"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35797","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of precise prevention strategies for the occurrence and progression of coronary atherosclerotic heart disease using machine learning","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35797"}}